Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Conus toxins: targets and properties.

Christine E Heading1

  • 1The Open University, Department of Biological Sciences, Walton Hall, Milton Keynes, MK7 6AA UK. moore11@globalnet.co.uk

Idrugs : the Investigational Drugs Journal
|November 20, 2004
PubMed
Summary

Conus snail venoms contain numerous potent peptides targeting mammalian ion channels. These conopeptides offer therapeutic potential for nervous system disorders but face bioavailability and toxicity challenges.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Gender issues and the pharmacotherapy of substance abuse.

IDrugs : the investigational drugs journal·2008
Same author

Drug evaluation: CYT-002-NicQb, a therapeutic vaccine for the treatment of nicotine addiction.

Current opinion in investigational drugs (London, England : 2000)·2007
Same author

Vivitrex (Alkermes/Cephalon).

Current opinion in investigational drugs (London, England : 2000)·2006
Same author

NicVAX (Nabi Biopharmaceuticals).

IDrugs : the investigational drugs journal·2003
Same author

Recent advances against substance abuse.

IDrugs : the investigational drugs journal·2003
Same author

TA-CD. Xenova.

IDrugs : the investigational drugs journal·2003

Area of Science:

  • Marine Biology
  • Neuropharmacology
  • Biochemistry

Background:

  • Conus snail venoms are a rich source of bioactive peptides, known as conopeptides.
  • These peptides exhibit high specificity for mammalian receptor sites, particularly ion channels.
  • The diversity of Conus species (~500) suggests a vast repertoire of conopeptides.

Purpose of the Study:

  • To explore the therapeutic potential of conopeptides derived from Conus snail venoms.
  • To identify the specific receptor targets of conopeptides within the mammalian nervous system.
  • To address challenges related to the development of conopeptide-based therapeutics.

Main Methods:

  • Analysis of Conus snail venom composition.
  • Characterization of conopeptide interactions with ion channels (voltage-gated, ligand-gated, G-protein linked).
  • Investigation of potential physiological targets in the central and peripheral nervous systems.

Main Results:

  • Conopeptides demonstrate potent specificity for various mammalian ion channels.
  • Identified targets include voltage-gated, ligand-gated, and G-protein linked ion channels.
  • Central nervous system targets are prominent in advanced therapeutic development.

Conclusions:

  • Conus snail venoms represent a significant resource for novel neurotherapeutics.
  • Conopeptides targeting the central nervous system hold promise but require overcoming bioavailability and toxicity issues.
  • Further research is needed to optimize conopeptide delivery and safety for therapeutic applications.

Related Experiment Videos